Guidelines International Network | Guidelines International Network (GIN)

S2k Leitlinie zu Diagnostik und Therapie der systemischen Sklerose. S2k-LL (DGRh)

Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: S2k guidelines for diagnostics and therapy of systemic sclerosis
Expected Publication Date: 31/12/2024
Publication Scope: management
Countries of Application: Germany
Languages: German
Authors: AWMF (DE)

MeSH Terms: Diverticulitis (C01.539.463.298); Diverticulitis (C06.405.205.298); Diverticulitis; Colonic (C06.405.469.158.587.500)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: S3 guideline on diverticular disease / diverticulitis
Keywords: Divertikulose, Divertikulitis, Divertikelkrankheit
Date for Review: 15/10/2026
Publication Date: 30/11/2021
Publication Scope: assessment; management; prevention
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2014

Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: S3 guideline on immunosuppression after pediatric kidney transplantation (LL-PädNTx)
Expected Publication Date: 31/12/2024
Publication Scope: management
Countries of Application: Germany
Languages: German
Authors: AWMF (DE)

MeSH Terms: Amphetamine-Related Disorders (F03.900.225); Mental Disorders (F03)
Guideline Contact: Corinna Schaefer (schaefer@azq.de)
English Title Translation: S3 Practice Guideline Methamphetamine-related Disorders
Publication Scope: assessment; management; prevention; treatment
Countries of Application: Germany
Guideline Publication Status: Published
Languages: English; German
Authors: AQuMed/AEZQ (DE)
Publication Year: 2016

MeSH Terms: Pancreatic Diseases (C06.689)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: S3 guideline on pancreatitis
Keywords: Akute Pankreatitis, chronische Pankreatitis, Diagnostik, Therapie, Ernährung
Date for Review: 30/04/2026
Publication Date: 10/09/2021
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2021

MeSH Terms: Oncology Nursing (H02.478.676.605); Neoplasms (C04); Antineoplastic Protocols (E02.183.750); Antineoplastic Agents (D27.505.954.248); Medication Systems (N04.452.528)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2012

MeSH Terms: Antineoplastic Agents (D27.505.954.248); Outpatients (M01.643.630); Ambulatory Care (E02.760.106)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2012

MeSH Terms: Practice Guideline (V02.515.500); Guideline (V02.515); Practice Guidelines as Topic (N04.761.700.350.650)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2014

MeSH Terms: occupational exposure, health personnal, oncologic nursing, oncology service, hospital, pharmacy, pharmacy service, antineoplastic agents, occupational diseases, abnormalities, drug-induced, environmental exposure, carcinogens, teratogens, drug toxicity, hazardous substances, phaseal, closed-system, drug compounding, choclave, Spiros, onguard, baxa, Tevadaptor, environmental monitoring, pregnancy, neoplasms, nurses, health care worker, pharmacist, pharmacy technician, adverse outcome, cancer chemotherapy, chemotherapy, biological monitoring
Guideline Contact: Nadia Coakley; pebconc@mcmaster.ca
Keywords: occupational exposure, health personnal, oncologic nursing, antineoplastic agents, occupational diseases
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 2022-09-26
Date of Last Evidence Search: 2022-08-27
Methods Applied: Systematic review-based, Externally reviewed, Evidence quality assessment, Patient/survivors/caregivers participation
Publication Scope: Guidelines
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2022